ESC Premium Access

Real world outcomes for clopidogrel versus ticagrelor treated patients with acute coronary syndrome: a systematic literature review and meta-analysis

Congress Presentation

About the speaker

Professor Dirk Sibbing

Ludwig Maximilians University, Munich (Germany)
9 presentations

5 more presentations in this session

Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.

Speaker: Doctor F. Marin (Murcia, ES)


One-year efficacy and safety of prasugrel and ticagrelor in patients with Acute Coronary Syndromes: results from a prospective and multicenter ACHILLES Registry.

Speaker: Doctor M. Esteve Pastor (Murcia, ES)


Ischemic-bleeding balance according to history of prior bleeding in patients with acute coronary syndrome during treatment with dual antiplatelet therapy

Speaker: Ms B. Caneiro-Queija (Vigo, ES)


Percutaneous coronary intervention in the age of frailty

Speaker: Doctor M. Bergami (Bologna, IT)


Thrombus aspiration in combination with glycoprotein IIb/IIIa inhibitors with or without stent implantation in patients presenting with STEMI and high thrombus burden

Speaker: Mr K. Kintis (Athens, GR)


Access the full session

Insights from acute coronary syndrome registries

Speakers: Professor D. Sibbing, Doctor F. Marin, Doctor M. Esteve Pastor, Ms B. Caneiro-Queija, Doctor M. Bergami...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb